Abstract PS09-09: Multiomics profiling and molecular classification refine precision treatment strategies for HER2-positive breast cancer
Yuwei Li(State Grid Corporation of China (China)), Zhi‐Ming Shao(Fudan University Shanghai Cancer Center), Ding Ma(Fudan University Shanghai Cancer Center), Tong‐Ming Fu(Doylestown Hospital), Cai‐Jin Lin(Shanghai Medical College of Fudan University), Ming Li(Air Force Medical University), Shen Zhao(Sun Yat-sen University), Hong Lv(Nanjing Maternity and Child Health Care Hospital), Ying Wang(Hebei Medical University), Xi Jin(Sichuan University), Yu-Zheng Xu(Shanghai Cancer Institute), Yi-Fan Zhou(Shanghai Medical College of Fudan University), Yi Xiao(Tongji Hospital), Lei-Jie Dai(Fudan University Shanghai Cancer Center), Xiangrong Wu(Shanghai Medical College of Fudan University), Yi‐Zhou Jiang(Shanghai Medical College of Fudan University)
Cited by 1
Related Papers
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
|Nature|2002|1.2k
Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination
|Science|2000|885
Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 <i>gag</i> Gene
|Journal of Virology|2003|398
Use of overlapping peptide mixtures as antigens for cytokine flow cytometry
|Journal of Immunological Methods|2001|352